| Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease T Botta‐Orfila, X Morató, Y Compta, JJ Lozano, N Falgas, F Valldeoriola, ... Journal of neuroscience research 92 (8), 1071-1077, 2014 | 157 | 2014 |
| Systematic protein–protein interaction mapping for clinically relevant human GPCR s K Sokolina, S Kittanakom, J Snider, M Kotlyar, P Maurice, J Gandía, ... Molecular systems biology 13 (3), 918, 2017 | 85 | 2017 |
| MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients E Tolosa, T Botta-Orfila, X Morató, C Calatayud, R Ferrer-Lorente, ... Neurobiology of aging 69, 283-291, 2018 | 66 | 2018 |
| The role of parkinson's disease‐associated receptor GPR 37 in the hippocampus: functional interplay with the adenosinergic system JP Lopes, X Morató, C Souza, C Pinhal, NJ Machado, PM Canas, ... Journal of Neurochemistry 134 (1), 135-146, 2015 | 58 | 2015 |
| The Parkinson’s disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo X Morató, R Luján, M López-Cano, J Gandía, I Stagljar, M Watanabe, ... Scientific Reports 7 (1), 9452, 2017 | 40 | 2017 |
| The Parkinson's disease‐associated GPR 37 receptor‐mediated cytotoxicity is controlled by its intracellular cysteine‐rich domain J Gandía, V Fernández‐Dueñas, X Morató, G Caltabiano, ... Journal of Neurochemistry 125 (3), 362-372, 2013 | 36 | 2013 |
| Dopamine D2 receptor-mediated modulation of adenosine A2A receptor agonist binding within the A2AR/D2R oligomer framework V Fernández-Dueñas, M Gómez-Soler, X Morató, F Núñez, A Das, ... Neurochemistry international 63 (1), 42-46, 2013 | 34 | 2013 |
| Triglyceride form of docosahexaenoic acid mediates neuroprotection in experimental parkinsonism M Gómez-Soler, B Cordobilla, X Morató, V Fernández-Dueñas, ... Frontiers in neuroscience 12, 343638, 2018 | 32 | 2018 |
| Coassembly and coupling of SK2 channels and mGlu5 receptors G García-Negredo, D Soto, J Llorente, X Morató, KMO Galenkamp, ... Journal of Neuroscience 34 (44), 14793-14802, 2014 | 22 | 2014 |
| Ecto-GPR37: A potential biomarker for Parkinson’s disease X Morató, P Garcia-Esparcia, J Argerich, F Llorens, I Zerr, W Paslawski, ... Translational neurodegeneration 10, 1-14, 2021 | 20 | 2021 |
| Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent J Gandía, X Morató, I Stagljar, V Fernández-Duenas, F Ciruela Behavioural brain research 288, 103-106, 2015 | 17 | 2015 |
| Angiotensin II type 1/adenosine A2A receptor oligomers: a novel target for tardive dyskinesia PA Oliveira, JAR Dalton, M López-Cano, A Ricarte, X Morató, FC Matheus, ... Scientific Reports 7 (1), 1857, 2017 | 14 | 2017 |
| Inhibition of tryptophan hydroxylases and monoamine oxidase-A by the proton pump inhibitor, omeprazole—in vitro and in vivo investigations N Betari, K Sahlholm, X Morató, H Godoy-Marín, O Jáuregui, K Teigen, ... Frontiers in Pharmacology 11, 593416, 2020 | 13 | 2020 |
| Chronic adenosine A2A receptor blockade induces locomotor sensitization and potentiates striatal LTD IN GPR37‐deficient mice X Morato, FQ Gonçalves, JP Lopes, O Jauregui, C Soler, ... Journal of Neurochemistry 148 (6), 796-809, 2019 | 13 | 2019 |
| GPR37 is processed in the N‐terminal ectodomain by ADAM10 and furin SO Mattila, HE Tuhkanen, JJ Lackman, A Konzack, X Morató Arús, ... The FASEB Journal, 2021, vol. 35, num. 6, 2021 | 11 | 2021 |
| Parkinson’s disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses D Rial, X Morato, JI Real, FQ Gonçalves, I Stagljar, FC Pereira, ... Neuroscience Letters 638, 162-166, 2017 | 10 | 2017 |
| Co-immunoprecipitation from brain X Morató, DO Borroto-Escuela, K Fuxe, V Fernández-Dueñas, F Ciruela Receptor and Ion Channel Detection in the Brain, 19-30, 2021 | 9 | 2021 |
| Brain membrane fractionation: an ex vivo approach to assess subsynaptic protein localization X Morató, M López-Cano, PM Canas, RA Cunha, F Ciruela JoVE (Journal of Visualized Experiments), e55661, 2017 | 8 | 2017 |
| Metabotropic glutamate type 5 receptor requires contactin-associated protein 1 to control memory formation X Morató, R Luján, N Gonçalves, M Watanabe, X Altafaj, AL Carvalho, ... Human Molecular Genetics 27 (20), 3528-3541, 2018 | 7 | 2018 |
| Synthesis and characterization of a new bivalent ligand combining Caffeine and Docosahexaenoic Acid V Fernández-Dueñas, J Azuaje, X Morató, B Cordobilla, JC Domingo, ... Molecules 22 (3), 366, 2017 | 7 | 2017 |
Francisco CiruelaIDIBELL-Universitat de BarcelonaVerified email at ub.edu
